Navigation Links
Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show
Date:5/21/2013

TEANECK, N.J., May 21, 2013 /PRNewswire-iReach/ -- The 2013 Pharma ChemOutsourcing Show slated for Sept 17-19 in NJ has attracted the greatest number of "Emerging" small molecule biotech company chemists ever, reports its President, Mark Alexay .  "No one saw this coming", commented Alexay.  "But suddenly everyone plans to attend this year.  The show's still 4 months away and we may end up attracting hundreds of different companies.  This is a big surprise and great news for attendees". Thecurrent list of 80 attending pharmaceutical, emerging, virtual, and other small molecule biotech companies is at http://chemoutsourcing.com/popup.php

Alexay elaborated, "The Emerging companies need timely information about how to get their molecules scaled up quickly and properly.  They also need to meet their suppliers in one place.  This is why they attend.  It's makes efficient use of their time without trips to Europe or Asia."    

"They have also remarked that it's helpful to benchmark best practices and meet their peers from other small molecule biotech companies.  There's no other show in the world that brings together so many chemists from "Emerging" and "Virtual" companies.  If small and lean is the new pharmaceutical industry drug development model then the show is well-positioned to serve it."

Pharma ChemOutsourcing is now in its 7th year and takes place every September at the Jersey Shore.  The show annually attracts 700-800 Pharmaceutical company chemists and suppliers of chemical services to the industry. The show emphasizes Outsourcing of Discovery and Medicinal Chemistry, Process Research, and  Chemical Development of Intermediates, API's, and Commercial Manufacturing.

"The goal from the outset was for the show to develop into an annual pharma chemist "cult classic" and it's taken the better part of a decade for that to happen",  Alexay continued.  "We're finally seeing the fruition of this vision.  People have made it clear that it serves a vital purpose for the industry by and makes good use of the scarcest resource of all – their time." 

The other major 2013 development announcement is that ChemOutsourcing has integrated the conference panel sessions into the exhibit halls.  As Alexay commented "In 2013 buyers and sellers will be integrated all day in a single area, the exhibit halls, where they will have ample opportunity to interact.  This completely changes the feel of the show".   

"In years past because attendees and exhibitors were segregated for large portions of the day it was awkward to meet new people and buyers were reluctant to enter the halls. Now the spontaneity and easy intimacy has been restored because everyone will be together without forced contact".  The current 2013 Exhibitor List may be found at http://chemoutsourcing.com/sponsors.php

Media Contact:

mark alexay, apaporis, llc, 201-452-4023, malexay@chemoutsourcing.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Apaporis, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer
2. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company launch educational campaign about emerging science in type 2 diabetes
3. NextDocs Launches QuickStart for Emerging Growth Companies
4. Treatment Adherence Emerging as Critical Theme in Improving Quality and Cost of US Healthcare
5. For Treatment of Extensive-Disease Small-Cell Lung Cancer (ED-SCLC), No Emerging Therapy is Likely to Replace Etoposide/Carboplatin as the Standard of Care Before 2022
6. Details of New Synthetic Vaccine for Emerging H7N9 Threat Revealed at BIO International Convention in Chicago, April 22-25
7. GlaxoSmithKline and A*STARs Institute of Chemical Engineering and Sciences to Develop new Medicines for Emerging Markets
8. For the Treatment of Lupus, the Emerging Therapies Epratuzumab and Lupuzor Have the Potential to Offer Improvements Over IV Belimumab in Reducing Disease Activity
9. Emerging Precision Medicine Powerhouse Changes Name to Increase Visibility and Overall Awesomeness
10. Emerging Data From Upsher-Smiths CNS Portfolio Highlighted At 2013 American Academy Of Neurology Meeting
11. Innophos CFO To Present At 2013 Sidoti Emerging Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 VolitionRx ... of Dr. Edward Futcher to the ... effective June 23, 2016.Dr. Futcher was also appointed ... Governance Committees.  As a non-executive member of the ... and strategic counsel to VolitionRx in connection with ...
(Date:6/23/2016)... Calif. , June 23, 2016 Any dentist ... many challenges of the current process. Many of them do ... of the technical difficulties and high laboratory costs involved. And ... to offer it at such a high cost that the ... it. Dr. Parsa Zadeh , founder of ...
(Date:6/23/2016)... , June 23, 2016 Research ... MEMS Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data ... analysis. Assessment of major trends with potential impact on the ... analysis of market segmentation which comprises of sub markets, regional ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... its strategic partnership with Connance, a healthcare industry leader providing predictive analytics ... proprietary technology combine to provide health systems, hospitals and ambulatory surgical centers ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a ... can give their videos a whole new perspective by using the title layers ... Film Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
Breaking Medicine News(10 mins):